90 related articles for article (PubMed ID: 7241378)
1. Stereoselective metabolism of mephenytoin in man.
Küpfer A; Roberts RK; Schenker S; Branch RA
J Pharmacol Exp Ther; 1981 Jul; 218(1):193-9. PubMed ID: 7241378
[No Abstract] [Full Text] [Related]
2. Stereoselective metabolism and disposition of the enantiomers of mephenytoin during chronic oral administration of the racemic drug in man.
Küpfer A; Desmond PV; Schenker S; Branch RA
J Pharmacol Exp Ther; 1982 Jun; 221(3):590-7. PubMed ID: 7086673
[No Abstract] [Full Text] [Related]
3. Stereoselectivity of differential routes of drug metabolism: the fate of the enantiomers of [14C]mephenytoin in the dog.
Küpfer A; Bircher J
J Pharmacol Exp Ther; 1979 May; 209(2):190-5. PubMed ID: 438994
[No Abstract] [Full Text] [Related]
4. A major pathway of mephenytoin metabolism in man. Aromatic hydroxylation to p-hydroxymephenytoin.
Küpfer A; Brilis GM; Watson JT; Harris TM
Drug Metab Dispos; 1980; 8(1):1-4. PubMed ID: 6102023
[TBL] [Abstract][Full Text] [Related]
5. Stereoselective mephobarbital hydroxylation cosegregates with mephenytoin hydroxylation.
Küpfer A; Branch RA
Clin Pharmacol Ther; 1985 Oct; 38(4):414-8. PubMed ID: 4042524
[TBL] [Abstract][Full Text] [Related]
6. Pharmacogenetic association between the formation of 4-hydroxymephenytoin and a new metabolite of S-mephenytoin in man.
Wedlund PJ; Sweetman BJ; Wilkinson GR; Branch RA
Drug Metab Dispos; 1987; 15(2):277-9. PubMed ID: 2882992
[No Abstract] [Full Text] [Related]
7. Characterization of mephenytoin metabolites in human urine by gas chromatography and mass spectrometry.
Lynn RK; Bauer JE; Gordon WP; Smith RG; Griffin D; Thompson RM; Jenkins R; Gerber N
Drug Metab Dispos; 1979; 7(3):138-44. PubMed ID: 38083
[TBL] [Abstract][Full Text] [Related]
8. Stereoselective metabolism, pharmacokinetics and biliary elimination of phenylethylhydantoin (Nirvanol) in the dog.
Küpfer A; Bircher J; Preisig R
J Pharmacol Exp Ther; 1977 Dec; 203(3):493-9. PubMed ID: 925954
[TBL] [Abstract][Full Text] [Related]
9. Mephenytoin stereoselective elimination in the rat: II. Comparison of mephenytoin stereoselective clearance during chronic intravenous and hepatic portal vein administration.
Akrawi SH; Wedlund PJ
Eur J Drug Metab Pharmacokinet; 1989; 14(4):269-78. PubMed ID: 2633921
[TBL] [Abstract][Full Text] [Related]
10. 5-ethyl-5-phenylhydantoin N-glucuronide, the major urinary metabolite of 5-ethyl-5-phenylhydantoin (Nirvanol) in the dog.
Maguire JH; Butler TC; Dudley KH
Drug Metab Dispos; 1982; 10(6):595-8. PubMed ID: 6130906
[TBL] [Abstract][Full Text] [Related]
11. Analysis of hydroxylated and demethylated metabolites of mephenytoin in man and laboratory animals using gas-liquid chromatography and high-performance liquid chromatography.
Küpfer A; James R; Carr K; Branch R
J Chromatogr; 1982 Oct; 232(1):93-100. PubMed ID: 7142342
[TBL] [Abstract][Full Text] [Related]
12. Mephenytoin hydroxylation deficiency: kinetics after repeated doses.
Küpfer A; Desmond P; Patwardhan R; Schenker S; Branch RA
Clin Pharmacol Ther; 1984 Jan; 35(1):33-9. PubMed ID: 6690169
[TBL] [Abstract][Full Text] [Related]
13. Genetic polymorphism of mephenytoin p(4')-hydroxylation: difference between Orientals and Caucasians.
Jurima M; Inaba T; Kadar D; Kalow W
Br J Clin Pharmacol; 1985 Apr; 19(4):483-7. PubMed ID: 3994895
[TBL] [Abstract][Full Text] [Related]
14. Increased systemic availability of drugs during acute ethanol intoxication: studies with mephenytoin in the dog.
Zysset T; Preisig R; Bircher J
J Pharmacol Exp Ther; 1980 Apr; 213(1):173-8. PubMed ID: 7188964
[TBL] [Abstract][Full Text] [Related]
15. Assay of mephenytoin metabolism in human liver microsomes by high-performance liquid chromatography.
Meier UT; Kronbach T; Meyer UA
Anal Biochem; 1985 Dec; 151(2):286-91. PubMed ID: 4096368
[TBL] [Abstract][Full Text] [Related]
16. Family studies of mephenytoin hydroxylation deficiency.
Inaba T; Jurima M; Kalow W
Am J Hum Genet; 1986 May; 38(5):768-72. PubMed ID: 3717162
[TBL] [Abstract][Full Text] [Related]
17. Evidence for the epoxide-diol pathway in the biotransformation of mephenytoin.
Gerber N; Thompson RM; Smith RG; Lynn RK
Epilepsia; 1979 Jun; 20(3):287-94. PubMed ID: 446437
[TBL] [Abstract][Full Text] [Related]
18. Mephenytoin and sparteine oxidation: genetic polymorphisms in Denmark.
Drøhse A; Bathum L; Brøsen K; Gram LF
Br J Clin Pharmacol; 1989 May; 27(5):620-5. PubMed ID: 2757884
[TBL] [Abstract][Full Text] [Related]
19. Determination of mephenytoin stereoselective oxidative metabolism in urine by chiral liquid chromatography employing beta-cyclodextrin as a mobile phase additive.
Róna K; Szabó I
J Chromatogr; 1992 Jan; 573(1):173-7. PubMed ID: 1564100
[TBL] [Abstract][Full Text] [Related]
20. Stereoselectivity of the arene epoxide pathway of mephenytoin hydroxylation in man.
Küpfer A; Lawson J; Branch RA
Epilepsia; 1984 Feb; 25(1):1-7. PubMed ID: 6420144
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
